Health Care M&A Weekly Deals, The Week Ending June 9, 2017

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report.

This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.

Behavioral Health Care

   
Acquirer Target Price
Perimeter Healthcare Beacon Children’s Hospital N/A
Summit BHC Women in New Recovery N/A

Biotechnology

   
Acquirer Target Price
QIAGEN N.V. Worldwide license to biomarkers N/A

eHealth

   
Acquirer Target Price
Clariture Health, Inc. Aegis N/A
GTCR GreatCall, Inc. N/A

Hospitals

   
Acquirer Target Price
Alecto Healthcare Services LLC 2 hospitals in the Ohio Valley region N/A

Long-Term Care

   
Acquirer Target Price
Granite Investment Group Tabor Crest Memory Care N/A
The Ensign Group, Inc. 4 senior care facilities N/A
CareTrust REIT, Inc. The Rio at Cabezon & The Rio at Fox Hollow N/A
National Health Investors, Inc. Assisted Living Community $10.4 million
Hernandez Family Ventures Pointe North Gables $7.8 million
Sienna Senior Living Rosewood Retirement Residence $7.27 million
Korian Senior Assist portfolio N/A
Owner/operator Southern Traditions Nursing and Rehab $2.7 million

Medical Devices

   
Acquirer Target Price
Allergan plc Keller Medical, Inc. N/A

Pharmaceuticals

   
Acquirer Target Price
Consortium of investors SciClone Pharmaceuticals Inc. $605 million
Grünenthal Group Global rights to Zomig® $200 million
Taiba Healthcare Rights to Envarsus XR N/A

Physician Medical Groups

   
Acquirer Target Price
Avista Capital Partners National Spine & Pain Centers, LLC N/A

Other Services

   
Acquirer Target Price
Novanta Inc. World of Medicine GmbH $128.8 million
Key Surgical Interlock Medizintechnik GmbH N/A
The Carlyle Group and GTCR LLC Albany Molecular Research, Inc. $1.61 billion
UCB Pharma, Ltd. Beryllium Discovery, LLC N/A